Stay updated on BCMA CAR-T in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR-T in Multiple Myeloma Clinical Trial page.

Latest updates to the BCMA CAR-T in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. The phrase 'Here’s how you know' has been modified, suggesting a change in the presentation or explanation of information.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-02-25.SummaryDifference0.7%
- Check89 days agoChange DetectedThe page now includes information about BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease, with a new date of 2025-02-25, while the previous mention of the therapy without the plasma cell disease specification has been removed.SummaryDifference7%
- Check111 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
Stay in the know with updates to BCMA CAR-T in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR-T in Multiple Myeloma Clinical Trial page.